Relay Therapeutics Inc. (RLAY)
3.98
-0.36 (-8.40%)
At close: Jan 15, 2025, 1:37 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -341.97M | -290.51M | -363.87M | -52.41M | -75.31M | -48.78M |
| Depreciation & Amortization | 5.27M | 4.13M | 3.92M | 3.55M | 2.85M | 2.15M |
| Stock-Based Compensation | 86.03M | 56.14M | 48.45M | 31.96M | 4.46M | 2.89M |
| Other Working Capital | -35.28M | 9.16M | 277.00K | 571.00K | 1.31M | -1.63M |
| Other Non-Cash Items | -17.18M | -10.49M | 137.69M | -416.00K | -2.44M | 9.00K |
| Deferred Income Tax | n/a | n/a | 2.05M | n/a | n/a | n/a |
| Change in Working Capital | -32.46M | 11.25M | 97.34M | -85.17M | 4.31M | -400.00K |
| Operating Cash Flow | -300.32M | -229.49M | -74.41M | -102.49M | -66.13M | -44.13M |
| Capital Expenditures | -4.13M | -9.06M | -3.47M | -1.93M | -8.00M | -1.69M |
| Acquisitions | n/a | 179.68M | -25.30M | -83.60M | 20.00K | 7.00K |
| Purchase of Investments | -385.54M | -535.42M | -980.66M | -266.45M | -553.52M | n/a |
| Sales Maturities Of Investments | 647.30M | 355.74M | 529.92M | 350.06M | 242.47M | n/a |
| Other Investing Acitivies | n/a | -179.68M | -450.74M | 83.60M | -311.02M | 7.00K |
| Investing Cash Flow | 257.63M | -188.75M | -479.51M | 81.67M | -319.02M | -1.68M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -82.00K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 4.47M | 5.17M | 5.88M | 1.22M | 5.61M | 394.97M |
| Financial Cash Flow | 34.75M | 289.91M | 388.09M | 426.51M | 5.61M | 394.97M |
| Net Cash Flow | -7.93M | -128.32M | -165.83M | 405.69M | -379.55M | 349.16M |
| Free Cash Flow | -304.44M | -238.55M | -77.88M | -104.42M | -74.14M | -45.82M |